[{"address1": "1489 W. Warm Springs Road", "address2": "Suite 110", "city": "Henderson", "state": "NV", "zip": "89014", "country": "United States", "phone": "702-757-6133", "website": "https://zurabio.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Someit  Sidhu M.D.", "age": 34, "title": "Founder & Director", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 442937, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Verender S. Badial", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 374916, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael D. Howell Ph.D.", "age": 46, "title": "Chief Scientific Officer & Head of Translational Medicine", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 1968840, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kimberly Ann Davis", "age": 55, "title": "Chief Legal Officer & Secretary", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 2155202, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Lisicki", "age": 56, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Whale Ph.D.", "age": 49, "title": "Chief Technology Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Theresa  Lowry", "age": 49, "title": "Chief Human Resources Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Brady", "title": "Head of Business Development", "fiscalYear": 2023, "totalPay": 125051, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kiran  Nistala MBBS, Ph.D.", "age": 50, "title": "Chief Medical Officer & Head of Development", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.95, "open": 3.9, "dayLow": 3.72, "dayHigh": 4.03, "regularMarketPreviousClose": 3.95, "regularMarketOpen": 3.9, "regularMarketDayLow": 3.72, "regularMarketDayHigh": 4.03, "beta": 0.156, "trailingPE": 6.614035, "forwardPE": -5.8, "volume": 254803, "regularMarketVolume": 254803, "averageVolume": 314730, "averageVolume10days": 304760, "averageDailyVolume10Day": 304760, "bid": 3.75, "ask": 3.8, "bidSize": 400, "askSize": 300, "marketCap": 238290768, "fiftyTwoWeekLow": 2.0, "fiftyTwoWeekHigh": 7.22, "fiftyDayAverage": 3.6598, "twoHundredDayAverage": 3.894475, "currency": "USD", "enterpriseValue": 92566000, "floatShares": 12421886, "sharesOutstanding": 63207100, "sharesShort": 4018623, "sharesShortPriorMonth": 1786096, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0598, "heldPercentInsiders": 0.37469003, "heldPercentInstitutions": 0.57015, "shortRatio": 9.69, "shortPercentOfFloat": 0.0837, "bookValue": 2.458, "priceToBook": 1.5337673, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -27944000, "trailingEps": 0.57, "forwardEps": -0.65, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ZURA", "underlyingSymbol": "ZURA", "shortName": "Zura Bio Limited", "longName": "Zura Bio Limited", "firstTradeDateEpochUtc": 1679405400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d708db67-1e4e-350b-a79f-5dd0f51fa410", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.77, "targetHighPrice": 26.0, "targetLowPrice": 10.0, "targetMeanPrice": 17.17, "targetMedianPrice": 16.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 188443008, "totalCashPerShare": 2.804, "quickRatio": 12.502, "currentRatio": 12.57, "returnOnAssets": -0.16986, "returnOnEquity": -0.2644, "freeCashflow": -28050000, "operatingCashflow": -18223000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]